Search

Your search keyword '"Donadio MVF"' showing total 84 results

Search Constraints

Start Over You searched for: Author "Donadio MVF" Remove constraint Author: "Donadio MVF"
84 results on '"Donadio MVF"'

Search Results

1. Modified Shuttle Test Distance Correlates With Peak Oxygen Uptake in Children and Adolescents With Severe Therapy-Resistant Asthma

2. The Borg scale is accurate in children and adolescents older than 9 years with cystic fibrosis.

3. Optimum design parameters for a therapist-constructed positive-expiratory-pressure therapy bottle device.

5. Using reporting guidelines in sports and exercise medicine research: why and how to raise the bar?

6. Feasibility of performing the 3-minute step test with remote supervision in children and adolescents with cystic fibrosis: A comparative study.

7. Enhancing reporting through structure: a before and after study on the effectiveness of SPIRIT-based templates to improve the completeness of reporting of randomized controlled trial protocols.

8. Baccharis anomala DC. extract reduces inflammation and attenuates hepatic fibrosis in vivo by decreasing NF-kB and extracellular matrix compounds.

9. Bezafibrate reduces the damage, activation and mechanical properties of lung fibroblast cells induced by hydrogen peroxide.

10. Effects and safety of hypertonic saline combined with airway clearance in non-hospitalized children with recurrent wheezing.

11. Changes in lung function in adolescents with substance use disorders: an exploratory study.

12. Mechanisms of ventilatory limitation to maximum exercise in children and adolescents with chronic airway diseases.

13. Impact of COVID-19 social distancing recommendations on pulmonary function, nutritional status, and morbidity in patients with cystic fibrosis.

14. Ventilatory Threshold and Risk of Pulmonary Exacerbations in Cystic Fibrosis.

16. Impact of asthma on heart rate variability in children and adolescents: Systematic review and meta-analysis.

17. Coumaric acid from M. polymorphum extracts reverses the activated state of hepatic stellate cells (GRX) and inhibits their proliferation by decreasing the p53/p21 pathway.

18. Prevalence of dyslipidemia, atherogenic and cardiovascular risk in overweight and obese adolescents.

19. Simvastatin attenuates inflammatory process on LPS-induced acute lung injury in mice.

20. Impact of maternal physical exercise on inflammatory and hypothalamic-pituitary-adrenal axis markers in the brain and lungs of prenatally stressed neonatal mice.

21. The Association of Field Test Outcomes with Peak Oxygen Uptake in Patients with Cystic Fibrosis: A Systematic Review.

22. The role of maternal exercise on placental, behavioral and genetic alterations induced by prenatal stress.

23. Lifestyle improvement reduces the consumption of ultra-processed foods in adults with metabolic syndrome.

24. Effects of Physical Training on Heart Rate Variability in Children and Adolescents with Chronic Diseases: A Systematic Review and Meta-analysis.

25. Heart rate variability, exercise capacity and levels of daily physical activity in children and adolescents with mild-to-moderate cystic fibrosis.

26. Is exercise and electrostimulation effective in improving muscle strength and cardiorespiratory fitness in children with cystic fibrosis and mild-to-moderate pulmonary impairment?: Randomized controlled trial.

27. Gestational stress alters maternal behavior and inflammatory markers in the olfactory bulb of lactating mice.

28. Octyl gallate decrease lymphocyte activation and regulates neutrophil extracellular traps release.

29. Determinants of exercise capacity in children and adolescents with severe therapy-resistant asthma.

30. Obstructive sleep apnea in children and adolescents with cystic fibrosis and preserved lung function or mild impairment: a systematic review and meta-analysis of prevalence.

31. Methoxyeugenol deactivates hepatic stellate cells and attenuates liver fibrosis and inflammation through a PPAR-ɣ and NF-kB mechanism.

32. Safety of airway clearance combined with bronchodilator and hypertonic saline in non-hospitalized infants with acute bronchiolitis.

33. Aerobic fitness is associated with extracellular DNA levels in the sputum of patients with cystic fibrosis.

34. Neuromuscular Electrical Stimulation Improves Muscle Strength, Biomechanics of Movement, and Functional Mobility in Children With Chronic Neurological Disorders: A Systematic Review and Meta-Analysis.

35. Association of sleep disorders with heart rate variability in children and adolescents with cystic fibrosis.

36. Comparison of physical fitness between healthy and mild-to-moderate asthmatic children with exercise symptoms: A cross-sectional study.

37. The modified shuttle test as a predictor of risk for hospitalization in youths with cystic fibrosis: A two-year follow-up study

38. Prenatal stress and KCl-induced depolarization modulate cell death, hypothalamic-pituitary-adrenal axis genes, oxidative and inflammatory response in primary cortical neurons.

39. Diagnostic performance of the physical activity-related question of the GINA questionnaire to detect exercise-induced bronchoconstriction in asthma.

40. Clinical use of the modified shuttle test in children with cystic fibrosis: Is one test sufficient?

41. Peripheral muscle strength is associated with aerobic fitness and use of antibiotics in patients with cystic fibrosis.

43. Continuous positive airway pressure acutely increases exercise duration in children with severe therapy-resistant asthma: a randomized crossover trial.

44. Sex-dependent metabolic effects of pregestational exercise on prenatally stressed mice.

45. Effects of a Short-Term Resistance-Training Program on Heart Rate Variability in Children With Cystic Fibrosis-A Randomized Controlled Trial.

46. Immediate Effects and Safety of High-Frequency Chest Wall Compression Compared to Airway Clearance Techniques in Non-Hospitalized Infants With Acute Viral Bronchiolitis.

47. Effects of running before pregnancy on long-term memory and hippocampal alterations induced by prenatal stress.

48. Therapeutic effect of uridine phosphorylase 1 (UPP1) inhibitor on liver fibrosis in vitro and in vivo.

49. FUNCTIONAL PERFORMANCE IN THE MODIFIED SHUTTLE TEST IN CHILDREN AND ADOLESCENTS WITH CYSTIC FIBROSIS.

50. CPBMF65, a synthetic human uridine phosphorylase-1 inhibitor, reduces HepG2 cell proliferation through cell cycle arrest and senescence.

Catalog

Books, media, physical & digital resources